Reduced messenger RNA expression level of p21Cip1 in human colorectal carcinoma tissues and its association with p53 gene mutation

International Journal of Cancer

Volumn 69, Issue 4, 1996, Pages 259-264

  Matsushita, Kazuyuki ^a,c   Kobayashi, Susumu ^a   Kato, Masataka ^a   Itoh, Yasushi ^a   Okuyama, Kazuaki ^a   Sakiyama, Shigeru ^b   Isono, Kaichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA CANCER CENTER   (Japan)

^c SAKURA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MESSENGER RNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOTTING, NORTHERN; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENE EXPRESSION; GENES, P53; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA, MESSENGER;

EID: 0029802296     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960822)69:4<259::AID-IJC3>3.0.CO;2-W     Document Type: Article

References (27)

1. BAKER, S.J., MARKOWITZ, S., FEARON, E.R., WILLSON, J.K.V. and VOGELSTEIN, B., Suppression of human colorectal carcinoma cell growth by wild-typep53. Science (Wash.), 249, 912-915 (1990).
2. CHIRGWIN, J.M., PRZBYLA, A.E., MACDONALD, R.J. and RUTTER, W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299 (1979).
3. CLARKE, A.R., PURDIE, C.A., HARRISON, D.J., MORRIS, R.G., BIRD, C.C., HOOPER, M.L. and WYLLIE, A.H., Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Land.), 362, 849-852 (1993).
4. DATTO, M.B., LI, Y., PANUS, J.F., HOWE, D.J., XIONG, Y. and WANG, X.F., Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. nat. Acad. Sci. (Wash.), 92, 5545-5549 (1995).
5. 1 arrest. Cell, 76, 1013-1023 (1994).
6. 1 arrest and apoptosis. Cancer Res., 54, 1169-1174 (1994).
7. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, E., KINZLER, K.W. and VOGELSTEIN. B., WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
8. FUJIWARA, T., GRIMM, E.A., MUKHOPADHYAY, T., CAI, D.W., OWENSCHAUB, L.B. and ROTH, J.A., A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res., 53, 4129-4133 (1993).
9. GOELTZ, S.E., HAMILTON, S.R. and VOGELSTEIN, B., Purification of DNA from formaldehyde fixed and paraffin embedded tissue. Biochem. biophys. Res. Comm., 130, 118-126 (1985).
10. 1 cyclin-dependent kinases. Cell, 75, 805-816 (1993).
11. HARRIS, C.C. and HOLLSTEIN, M., Clinical implications of the p53 tumor-suppressor gene. New Engl. J. Med., 329, 1318-1327 (1993).
12. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutation in human cancers. Science (Wash.), 253, 49-53 (1991).
13. HUNTER, T., Braking the cycle. Cell, 75, 839-841 (1993).
14. IMASEKI, H., HAYASHI, H., TAIRA, M., ITO, Y., TABATA, Y., ONODA, S., ISONO, K. and TATIBANA, M., Expression of c-myc oncogene in colorectal polyps as a biological marker for monitoring malignant potential. Cancer, 64, 704-709 (1989).
15. JOHNSON, M., DIMITROV, D., VOJTA, P.J., BARRETT, J.C., NODA, A., PEREIRA-SMITH, O.M. and SMITH, J.R., Evidence for a p53-independent pathway for upregulation of sdi1/cip1/waf1/p21 RNA in human cells. Mol. Carcinogen., 11, 59-64 (1994).
16. LI, C.Y., SUARDET, L. and LITTLE, J.B., Potential role of WAF1/Cip1/ p21 as a mediator of TGF-beta cytoinhibitory effect. J. biol. Chem., 270, 4971-4974 (1995).
17. Liu, T.J., ZHANG, W.W., TAYLOR, D.L., ROTH, J.A., GEOPFERT, H. and CLAYMAN, G.L., Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54, 3662-3667 (1994).
18. LOWE, S.W., SCHMITT, E.M., SMITH, S.W., OSBORNE, B.A. and JACKS, T., p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Land.), 362, 847-849 (1993).
19. MANIATIS, T., FRITSCH, E.F. AND SAMBROOK, J. (eds.), Molecular Cloning, pp. 7.43-7.52, Cold Spring Harbor, New York (1982).
20. MICHIELI, P., CHEDID, M., LIN, D., PIERCE, J.M., MERCER, W.E. and GIVOL, D., Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54, 3391-3395 (1994).
21. MURAKAMI, Y., HAYASHI, K., HIROHASHI, S. and SEKIYA, T., Aberration of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51, 5520-5525 (1991).
22. NODA, A., KING, Y., VENABLE, S.F., PEREIRA-SMITH, O.M. and SMITH, J.R., Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211, 90-98 (1994).
23. Cip1 in muscle and other terminally differentiating cells. Science (Wash.), 267, 1024-1027 (1995).
24. TADA, M., OMATA, M. and OHTO, M., Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res., 50, 1121-1124 (1990).
25. TOKUNAGA, K., NAKAMURA, Y., SAKATA, K., FUJIMORI, K., OHKUBO, M., SAWADA, K. and SAKIYAMA, S., Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res., 47, 5616-5619 (1987).
26. XIONG, Y., HANNON, G.J., ZHANG, H., CASSO, D., KOBAYASHI, R. and BEACH, D., p21 is a universal inhibitor of cyclin kinases. Nature (Loud.), 366, 701-704 (1993).
27. XIONG, Y., ZHANG, H. and BEACH, D., D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71, 505-514 (1992).